
The state of Arkansas is suing several drug manufacturers and pharmaceutical benefits managers over accusations that the companies are violating the state's deceptive trade practice laws. The accusations detail that the plaintiffs inflated the price of insulin for diabetics by conspiring in a manner that best benefited them instead of... Read More »